Share Price and Basic Stock Data
Last Updated: January 7, 2026, 8:26 pm
| PEG Ratio | 9.40 |
|---|
Analyst Insight & Comprehensive Analysis
AI Stock Ranker – Real-Time Fundamental Strength Score
Business Overview and Revenue Trends
Carysil Ltd operates in the ceramics, tiles, and sanitaryware industry, with a market capitalization of ₹2,510 Cr and a share price of ₹884. The company reported a steady increase in sales, rising from ₹594 Cr in FY 2023 to ₹684 Cr in FY 2024, and further to ₹816 Cr in FY 2025, indicating a robust growth trajectory. In the trailing twelve months (TTM), sales stood at ₹875 Cr. Quarterly sales figures also reflect this upward trend, with the most recent quarter (Sep 2023) reporting ₹164 Cr, which increased to ₹188 Cr by Dec 2023. This consistent growth in revenue showcases Carysil’s ability to capture market demand and enhance its operational footprint. The company has also managed to maintain a healthy operating profit margin (OPM) of 19%, which is competitive within the sector. Overall, Carysil’s revenue performance positions it as a resilient player in the ceramics and sanitaryware market, benefitting from rising consumer demand and effective operational strategies.
Profitability and Efficiency Metrics
Carysil’s profitability metrics illustrate a solid financial performance. The company reported a net profit of ₹82 Cr, translating to a return on equity (ROE) of 14.5% and a return on capital employed (ROCE) of 15.4%. The operating profit for FY 2025 stood at ₹140 Cr, with an operating profit margin (OPM) of 17%, slightly lower than previous years but still competitive. Quarterly operating profits have shown recovery, with the latest quarter (Jun 2025) reporting ₹44 Cr. The interest coverage ratio (ICR) was robust at 6.29x, indicating that Carysil comfortably meets its interest obligations. However, the cash conversion cycle (CCC) of 251 days may be a concern as it suggests a longer time between outlaying cash for goods and receiving cash from product sales. This could impact liquidity if not managed effectively. Overall, while profitability remains strong, the efficiency in managing working capital will be crucial for sustaining growth.
Balance Sheet Strength and Financial Ratios
Carysil’s balance sheet reflects a growing asset base, with total assets recorded at ₹1,046 Cr in FY 2025. The company’s reserves increased to ₹560 Cr, while borrowings stood at ₹235 Cr, indicating a sound capital structure with a debt-to-equity ratio of 0.50x. This ratio is favorable compared to typical sector norms, suggesting that Carysil maintains a balanced approach towards leveraging. The current ratio is reported at 1.51, indicating strong short-term liquidity, while the quick ratio of 0.87 signals potential liquidity constraints. The company’s financial ratios, including a price-to-book value (P/BV) of 3.37x, reflect market confidence but also suggest that the stock may be priced at a premium compared to its book value. Additionally, with a dividend payout ratio of 8.91%, Carysil is returning value to shareholders while still reinvesting in growth, which is a positive sign of financial health.
Shareholding Pattern and Investor Confidence
The shareholding pattern of Carysil Ltd reveals a diversified ownership structure, with promoters holding 41.34% of the equity, alongside institutional investors such as domestic institutional investors (DIIs) at 11.33% and foreign institutional investors (FIIs) at 1.44%. Public shareholders constitute 45.89% of the total ownership, reflecting a broad base of retail interest. The number of shareholders has seen a decline to 54,797, indicating potential consolidation among investors. The gradual decrease in promoter shareholding from 43.91% in Dec 2022 to the current level may raise questions about long-term commitment, though the stability of DII investment suggests ongoing confidence in the company’s prospects. Overall, the diverse shareholding structure and institutional backing provide a strong foundation for Carysil’s market position, although the trend in promoter holdings should be monitored closely.
Outlook, Risks, and Final Insight
Looking ahead, Carysil Ltd is positioned to leverage its growing sales and profitability, but it faces certain risks. The company must address its cash conversion cycle to enhance liquidity and operational efficiency. Additionally, fluctuations in raw material costs could impact margins, given the competitive nature of the ceramics industry. The current economic environment, characterized by rising interest rates, could also affect consumer spending in the housing sector, which is critical for Carysil’s growth. However, the company’s strong financial metrics, including a healthy ICR and a solid balance sheet, provide a buffer against potential downturns. If Carysil can effectively manage its working capital and maintain its growth trajectory, it will likely continue to attract investor interest and achieve sustainable growth in the future. The focus on operational efficiency and market expansion will be crucial to navigating the challenges ahead while capitalizing on emerging opportunities in the ceramics and sanitaryware market.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| Exxaro Tiles Ltd | 353 Cr. | 7.90 | 11.0/5.22 | 66.4 | 6.21 | 0.00 % | 3.49 % | 0.26 % | 1.00 |
| Carysil Ltd | 2,503 Cr. | 879 | 1,072/482 | 30.9 | 199 | 0.27 % | 15.4 % | 14.5 % | 2.00 |
| Somany Ceramics Ltd | 1,692 Cr. | 409 | 640/392 | 29.6 | 191 | 0.73 % | 11.5 % | 8.17 % | 2.00 |
| Orient Bell Ltd | 419 Cr. | 284 | 350/215 | 64.0 | 217 | 0.18 % | 2.38 % | 0.90 % | 10.0 |
| Nitco Ltd | 2,043 Cr. | 89.1 | 164/76.5 | 13.2 | 0.00 % | 42.9 % | % | 10.0 | |
| Industry Average | 3,520.78 Cr | 798.30 | 40.83 | 200.53 | 0.48% | 12.44% | 14.63% | 6.10 |
Quarterly Result
| Metric | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 139 | 138 | 146 | 142 | 164 | 188 | 191 | 201 | 207 | 203 | 204 | 227 | 241 |
| Expenses | 117 | 113 | 119 | 116 | 131 | 153 | 156 | 165 | 170 | 174 | 169 | 183 | 195 |
| Operating Profit | 22 | 25 | 26 | 26 | 33 | 35 | 35 | 36 | 37 | 29 | 35 | 44 | 46 |
| OPM % | 16% | 18% | 18% | 18% | 20% | 19% | 18% | 18% | 18% | 14% | 17% | 19% | 19% |
| Other Income | 0 | 0 | 1 | 1 | 1 | 1 | 2 | 1 | 2 | 4 | 2 | 1 | 5 |
| Interest | 4 | 4 | 4 | 5 | 5 | 6 | 6 | 6 | 6 | 6 | 5 | 5 | 5 |
| Depreciation | 6 | 7 | 7 | 7 | 8 | 8 | 9 | 9 | 10 | 9 | 8 | 9 | 10 |
| Profit before tax | 13 | 14 | 16 | 16 | 22 | 22 | 21 | 23 | 24 | 18 | 24 | 30 | 36 |
| Tax % | 26% | 15% | 23% | 25% | 28% | 31% | 26% | 30% | 27% | 31% | 20% | 24% | 25% |
| Net Profit | 9 | 12 | 12 | 12 | 16 | 15 | 16 | 16 | 17 | 13 | 19 | 23 | 27 |
| EPS in Rs | 3.46 | 4.50 | 4.64 | 4.32 | 5.76 | 5.72 | 5.79 | 5.91 | 5.91 | 4.40 | 6.54 | 8.02 | 9.56 |
Last Updated: December 27, 2025, 3:36 pm
Below is a detailed analysis of the quarterly data for Carysil Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Sales, as of Sep 2025, the value is 241.00 Cr.. The value appears strong and on an upward trend. It has increased from 227.00 Cr. (Jun 2025) to 241.00 Cr., marking an increase of 14.00 Cr..
- For Expenses, as of Sep 2025, the value is 195.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 183.00 Cr. (Jun 2025) to 195.00 Cr., marking an increase of 12.00 Cr..
- For Operating Profit, as of Sep 2025, the value is 46.00 Cr.. The value appears strong and on an upward trend. It has increased from 44.00 Cr. (Jun 2025) to 46.00 Cr., marking an increase of 2.00 Cr..
- For OPM %, as of Sep 2025, the value is 19.00%. The value remains steady. There is no change compared to the previous period (Jun 2025) which recorded 19.00%.
- For Other Income, as of Sep 2025, the value is 5.00 Cr.. The value appears strong and on an upward trend. It has increased from 1.00 Cr. (Jun 2025) to 5.00 Cr., marking an increase of 4.00 Cr..
- For Interest, as of Sep 2025, the value is 5.00 Cr.. The value remains steady. There is no change compared to the previous period (Jun 2025) which recorded 5.00 Cr..
- For Depreciation, as of Sep 2025, the value is 10.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 9.00 Cr. (Jun 2025) to 10.00 Cr., marking an increase of 1.00 Cr..
- For Profit before tax, as of Sep 2025, the value is 36.00 Cr.. The value appears strong and on an upward trend. It has increased from 30.00 Cr. (Jun 2025) to 36.00 Cr., marking an increase of 6.00 Cr..
- For Tax %, as of Sep 2025, the value is 25.00%. The value appears to be increasing, which may not be favorable. It has increased from 24.00% (Jun 2025) to 25.00%, marking an increase of 1.00%.
- For Net Profit, as of Sep 2025, the value is 27.00 Cr.. The value appears strong and on an upward trend. It has increased from 23.00 Cr. (Jun 2025) to 27.00 Cr., marking an increase of 4.00 Cr..
- For EPS in Rs, as of Sep 2025, the value is 9.56. The value appears strong and on an upward trend. It has increased from 8.02 (Jun 2025) to 9.56, marking an increase of 1.54.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: December 15, 2025, 4:00 am
| Metric | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 106 | 127 | 174 | 181 | 196 | 252 | 276 | 310 | 484 | 594 | 684 | 816 | 875 |
| Expenses | 87 | 103 | 143 | 154 | 169 | 209 | 229 | 243 | 379 | 484 | 553 | 675 | 721 |
| Operating Profit | 19 | 24 | 31 | 27 | 27 | 42 | 48 | 67 | 105 | 110 | 131 | 140 | 154 |
| OPM % | 18% | 19% | 18% | 15% | 14% | 17% | 17% | 22% | 22% | 18% | 19% | 17% | 18% |
| Other Income | 1 | 1 | 2 | 3 | 5 | 2 | 5 | 8 | 10 | 2 | 5 | 9 | 12 |
| Interest | 5 | 8 | 9 | 11 | 8 | 12 | 10 | 8 | 11 | 17 | 23 | 26 | 21 |
| Depreciation | 5 | 4 | 5 | 6 | 7 | 9 | 12 | 13 | 18 | 26 | 32 | 36 | 36 |
| Profit before tax | 10 | 13 | 18 | 13 | 17 | 24 | 30 | 54 | 86 | 68 | 81 | 88 | 108 |
| Tax % | 25% | 32% | 32% | 37% | 28% | 28% | 25% | 27% | 24% | 22% | 28% | 27% | |
| Net Profit | 8 | 9 | 12 | 8 | 12 | 17 | 23 | 39 | 65 | 53 | 58 | 64 | 82 |
| EPS in Rs | 3.43 | 3.75 | 4.21 | 2.80 | 4.61 | 6.65 | 8.27 | 14.65 | 24.26 | 19.58 | 21.59 | 22.43 | 28.52 |
| Dividend Payout % | 23% | 21% | 24% | 36% | 22% | 18% | 15% | 14% | 10% | 10% | 9% | 11% |
YoY Net Profit Growth
| Year | 2014-2015 | 2015-2016 | 2016-2017 | 2017-2018 | 2018-2019 | 2019-2020 | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 | 2024-2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| YoY Net Profit Growth (%) | 12.50% | 33.33% | -33.33% | 50.00% | 41.67% | 35.29% | 69.57% | 66.67% | -18.46% | 9.43% | 10.34% |
| Change in YoY Net Profit Growth (%) | 0.00% | 20.83% | -66.67% | 83.33% | -8.33% | -6.37% | 34.27% | -2.90% | -85.13% | 27.90% | 0.91% |
Carysil Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 11 years from 2014-2015 to 2024-2025.
Growth
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 20% |
| 5 Years: | 24% |
| 3 Years: | 19% |
| TTM: | 13% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 22% |
| 5 Years: | 24% |
| 3 Years: | 0% |
| TTM: | 14% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 21% |
| 5 Years: | 51% |
| 3 Years: | 8% |
| 1 Year: | 1% |
| Return on Equity | |
|---|---|
| 10 Years: | 17% |
| 5 Years: | 19% |
| 3 Years: | 17% |
| Last Year: | 14% |
Last Updated: September 5, 2025, 2:51 pm
Balance Sheet
Last Updated: December 4, 2025, 2:35 am
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 6 | 6 |
| Reserves | 29 | 37 | 74 | 107 | 113 | 130 | 152 | 186 | 248 | 298 | 349 | 521 | 560 |
| Borrowings | 39 | 73 | 67 | 80 | 92 | 97 | 102 | 107 | 150 | 235 | 312 | 276 | 235 |
| Other Liabilities | 23 | 32 | 52 | 41 | 50 | 59 | 65 | 93 | 150 | 174 | 178 | 182 | 244 |
| Total Liabilities | 97 | 147 | 199 | 233 | 260 | 291 | 325 | 391 | 553 | 712 | 845 | 985 | 1,046 |
| Fixed Assets | 35 | 58 | 67 | 98 | 111 | 119 | 125 | 152 | 206 | 328 | 404 | 414 | 414 |
| CWIP | 2 | 4 | 2 | 2 | 2 | 4 | 9 | 10 | 21 | 14 | 10 | 12 | 26 |
| Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Assets | 60 | 85 | 131 | 132 | 146 | 168 | 191 | 229 | 326 | 371 | 430 | 560 | 605 |
| Total Assets | 97 | 147 | 199 | 233 | 260 | 291 | 325 | 391 | 553 | 712 | 845 | 985 | 1,046 |
Below is a detailed analysis of the balance sheet data for Carysil Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Equity Capital, as of Sep 2025, the value is 6.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 6.00 Cr..
- For Reserves, as of Sep 2025, the value is 560.00 Cr.. The value appears strong and on an upward trend. It has increased from 521.00 Cr. (Mar 2025) to 560.00 Cr., marking an increase of 39.00 Cr..
- For Borrowings, as of Sep 2025, the value is 235.00 Cr.. The value appears to be improving (decreasing). Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has decreased from 276.00 Cr. (Mar 2025) to 235.00 Cr., marking a decrease of 41.00 Cr..
- For Other Liabilities, as of Sep 2025, the value is 244.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 182.00 Cr. (Mar 2025) to 244.00 Cr., marking an increase of 62.00 Cr..
- For Total Liabilities, as of Sep 2025, the value is 1,046.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 985.00 Cr. (Mar 2025) to 1,046.00 Cr., marking an increase of 61.00 Cr..
- For Fixed Assets, as of Sep 2025, the value is 414.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 414.00 Cr..
- For CWIP, as of Sep 2025, the value is 26.00 Cr.. The value appears strong and on an upward trend. It has increased from 12.00 Cr. (Mar 2025) to 26.00 Cr., marking an increase of 14.00 Cr..
- For Investments, as of Sep 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 0.00 Cr..
- For Other Assets, as of Sep 2025, the value is 605.00 Cr.. The value appears strong and on an upward trend. It has increased from 560.00 Cr. (Mar 2025) to 605.00 Cr., marking an increase of 45.00 Cr..
- For Total Assets, as of Sep 2025, the value is 1,046.00 Cr.. The value appears strong and on an upward trend. It has increased from 985.00 Cr. (Mar 2025) to 1,046.00 Cr., marking an increase of 61.00 Cr..
Notably, the Reserves (560.00 Cr.) exceed the Borrowings (235.00 Cr.), indicating a solid financial buffer.
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Free Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | -20.00 | -49.00 | -36.00 | -53.00 | -65.00 | -55.00 | -54.00 | -40.00 | -45.00 | -125.00 | -181.00 | -136.00 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 86 | 93 | 89 | 77 | 89 | 79 | 82 | 98 | 76 | 63 | 74 | 65 |
| Inventory Days | 206 | 239 | 184 | 216 | 213 | 170 | 180 | 161 | 212 | 184 | 285 | 290 |
| Days Payable | 131 | 120 | 174 | 138 | 167 | 99 | 87 | 124 | 162 | 111 | 143 | 105 |
| Cash Conversion Cycle | 160 | 212 | 99 | 155 | 135 | 150 | 175 | 136 | 126 | 137 | 216 | 251 |
| Working Capital Days | 15 | 6 | 14 | 18 | 11 | 22 | 34 | 41 | 40 | 19 | 25 | 49 |
| ROCE % | 23% | 22% | 20% | 14% | 12% | 16% | 16% | 22% | 27% | 18% | 17% | 15% |
Mutual Fund Holdings
| Fund Name | No of Shares | AUM (%) | Amount Invested (Cr) | Previous Number of Shares | Previous Date | Percentage Change |
|---|---|---|---|---|---|---|
| DSP Small Cap Fund | 1,000,000 | 0.6 | 101.29 | N/A | N/A | N/A |
Key Financial Ratios
| Month | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
|---|---|---|---|---|---|
| FaceValue | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 |
| Basic EPS (Rs.) | 22.75 | 21.59 | 19.59 | 24.26 | 14.66 |
| Diluted EPS (Rs.) | 22.41 | 21.55 | 19.52 | 24.13 | 14.66 |
| Cash EPS (Rs.) | 35.29 | 33.86 | 29.58 | 31.08 | 19.47 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 185.39 | 132.01 | 114.69 | 96.25 | 72.66 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 185.39 | 132.01 | 114.69 | 96.25 | 72.66 |
| Revenue From Operations / Share (Rs.) | 287.17 | 254.98 | 221.83 | 181.27 | 116.02 |
| PBDIT / Share (Rs.) | 51.81 | 50.00 | 40.71 | 42.48 | 27.65 |
| PBIT / Share (Rs.) | 39.17 | 37.90 | 30.86 | 35.84 | 22.90 |
| PBT / Share (Rs.) | 30.93 | 30.12 | 25.44 | 32.25 | 20.17 |
| Net Profit / Share (Rs.) | 22.65 | 21.76 | 19.73 | 24.45 | 14.73 |
| NP After MI And SOA / Share (Rs.) | 22.44 | 21.59 | 19.58 | 24.26 | 14.66 |
| PBDIT Margin (%) | 18.04 | 19.60 | 18.34 | 23.43 | 23.82 |
| PBIT Margin (%) | 13.64 | 14.86 | 13.91 | 19.76 | 19.73 |
| PBT Margin (%) | 10.77 | 11.81 | 11.46 | 17.78 | 17.38 |
| Net Profit Margin (%) | 7.88 | 8.53 | 8.89 | 13.48 | 12.69 |
| NP After MI And SOA Margin (%) | 7.81 | 8.46 | 8.82 | 13.38 | 12.63 |
| Return on Networth / Equity (%) | 12.10 | 16.35 | 17.27 | 25.52 | 20.43 |
| Return on Capital Employeed (%) | 17.50 | 20.74 | 20.55 | 30.78 | 27.17 |
| Return On Assets (%) | 6.46 | 6.85 | 7.35 | 11.70 | 10.00 |
| Long Term Debt / Equity (X) | 0.16 | 0.32 | 0.25 | 0.15 | 0.11 |
| Total Debt / Equity (X) | 0.50 | 0.84 | 0.72 | 0.54 | 0.49 |
| Asset Turnover Ratio (%) | 0.89 | 0.87 | 0.93 | 0.91 | 0.76 |
| Current Ratio (X) | 1.51 | 1.17 | 1.16 | 1.27 | 1.33 |
| Quick Ratio (X) | 0.87 | 0.67 | 0.74 | 0.83 | 1.00 |
| Inventory Turnover Ratio (X) | 4.14 | 4.50 | 1.98 | 2.47 | 1.80 |
| Dividend Payout Ratio (NP) (%) | 8.91 | 9.26 | 6.12 | 9.89 | 13.64 |
| Dividend Payout Ratio (CP) (%) | 5.70 | 5.93 | 4.07 | 7.76 | 10.30 |
| Earning Retention Ratio (%) | 91.09 | 90.74 | 93.88 | 90.11 | 86.36 |
| Cash Earning Retention Ratio (%) | 94.30 | 94.07 | 95.93 | 92.24 | 89.70 |
| Interest Coverage Ratio (X) | 6.29 | 6.43 | 7.50 | 11.83 | 10.11 |
| Interest Coverage Ratio (Post Tax) (X) | 3.75 | 3.80 | 4.64 | 7.81 | 6.38 |
| Enterprise Value (Cr.) | 1976.83 | 2921.68 | 1669.06 | 2347.37 | 903.84 |
| EV / Net Operating Revenue (X) | 2.42 | 4.27 | 2.81 | 4.85 | 2.92 |
| EV / EBITDA (X) | 13.43 | 21.79 | 15.32 | 20.70 | 12.25 |
| MarketCap / Net Operating Revenue (X) | 2.18 | 3.85 | 2.45 | 4.58 | 2.67 |
| Retention Ratios (%) | 91.08 | 90.73 | 93.87 | 90.10 | 86.35 |
| Price / BV (X) | 3.37 | 7.43 | 4.80 | 8.74 | 4.32 |
| Price / Net Operating Revenue (X) | 2.18 | 3.85 | 2.45 | 4.58 | 2.67 |
| EarningsYield | 0.03 | 0.02 | 0.03 | 0.02 | 0.04 |
After reviewing the key financial ratios for Carysil Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 25, the value is 2.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 2.00.
- For Basic EPS (Rs.), as of Mar 25, the value is 22.75. This value is within the healthy range. It has increased from 21.59 (Mar 24) to 22.75, marking an increase of 1.16.
- For Diluted EPS (Rs.), as of Mar 25, the value is 22.41. This value is within the healthy range. It has increased from 21.55 (Mar 24) to 22.41, marking an increase of 0.86.
- For Cash EPS (Rs.), as of Mar 25, the value is 35.29. This value is within the healthy range. It has increased from 33.86 (Mar 24) to 35.29, marking an increase of 1.43.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 185.39. It has increased from 132.01 (Mar 24) to 185.39, marking an increase of 53.38.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 185.39. It has increased from 132.01 (Mar 24) to 185.39, marking an increase of 53.38.
- For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 287.17. It has increased from 254.98 (Mar 24) to 287.17, marking an increase of 32.19.
- For PBDIT / Share (Rs.), as of Mar 25, the value is 51.81. This value is within the healthy range. It has increased from 50.00 (Mar 24) to 51.81, marking an increase of 1.81.
- For PBIT / Share (Rs.), as of Mar 25, the value is 39.17. This value is within the healthy range. It has increased from 37.90 (Mar 24) to 39.17, marking an increase of 1.27.
- For PBT / Share (Rs.), as of Mar 25, the value is 30.93. This value is within the healthy range. It has increased from 30.12 (Mar 24) to 30.93, marking an increase of 0.81.
- For Net Profit / Share (Rs.), as of Mar 25, the value is 22.65. This value is within the healthy range. It has increased from 21.76 (Mar 24) to 22.65, marking an increase of 0.89.
- For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is 22.44. This value is within the healthy range. It has increased from 21.59 (Mar 24) to 22.44, marking an increase of 0.85.
- For PBDIT Margin (%), as of Mar 25, the value is 18.04. This value is within the healthy range. It has decreased from 19.60 (Mar 24) to 18.04, marking a decrease of 1.56.
- For PBIT Margin (%), as of Mar 25, the value is 13.64. This value is within the healthy range. It has decreased from 14.86 (Mar 24) to 13.64, marking a decrease of 1.22.
- For PBT Margin (%), as of Mar 25, the value is 10.77. This value is within the healthy range. It has decreased from 11.81 (Mar 24) to 10.77, marking a decrease of 1.04.
- For Net Profit Margin (%), as of Mar 25, the value is 7.88. This value is within the healthy range. It has decreased from 8.53 (Mar 24) to 7.88, marking a decrease of 0.65.
- For NP After MI And SOA Margin (%), as of Mar 25, the value is 7.81. This value is below the healthy minimum of 8. It has decreased from 8.46 (Mar 24) to 7.81, marking a decrease of 0.65.
- For Return on Networth / Equity (%), as of Mar 25, the value is 12.10. This value is below the healthy minimum of 15. It has decreased from 16.35 (Mar 24) to 12.10, marking a decrease of 4.25.
- For Return on Capital Employeed (%), as of Mar 25, the value is 17.50. This value is within the healthy range. It has decreased from 20.74 (Mar 24) to 17.50, marking a decrease of 3.24.
- For Return On Assets (%), as of Mar 25, the value is 6.46. This value is within the healthy range. It has decreased from 6.85 (Mar 24) to 6.46, marking a decrease of 0.39.
- For Long Term Debt / Equity (X), as of Mar 25, the value is 0.16. This value is below the healthy minimum of 0.2. It has decreased from 0.32 (Mar 24) to 0.16, marking a decrease of 0.16.
- For Total Debt / Equity (X), as of Mar 25, the value is 0.50. This value is within the healthy range. It has decreased from 0.84 (Mar 24) to 0.50, marking a decrease of 0.34.
- For Asset Turnover Ratio (%), as of Mar 25, the value is 0.89. It has increased from 0.87 (Mar 24) to 0.89, marking an increase of 0.02.
- For Current Ratio (X), as of Mar 25, the value is 1.51. This value is within the healthy range. It has increased from 1.17 (Mar 24) to 1.51, marking an increase of 0.34.
- For Quick Ratio (X), as of Mar 25, the value is 0.87. This value is below the healthy minimum of 1. It has increased from 0.67 (Mar 24) to 0.87, marking an increase of 0.20.
- For Inventory Turnover Ratio (X), as of Mar 25, the value is 4.14. This value is within the healthy range. It has decreased from 4.50 (Mar 24) to 4.14, marking a decrease of 0.36.
- For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is 8.91. This value is below the healthy minimum of 20. It has decreased from 9.26 (Mar 24) to 8.91, marking a decrease of 0.35.
- For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 5.70. This value is below the healthy minimum of 20. It has decreased from 5.93 (Mar 24) to 5.70, marking a decrease of 0.23.
- For Earning Retention Ratio (%), as of Mar 25, the value is 91.09. This value exceeds the healthy maximum of 70. It has increased from 90.74 (Mar 24) to 91.09, marking an increase of 0.35.
- For Cash Earning Retention Ratio (%), as of Mar 25, the value is 94.30. This value exceeds the healthy maximum of 70. It has increased from 94.07 (Mar 24) to 94.30, marking an increase of 0.23.
- For Interest Coverage Ratio (X), as of Mar 25, the value is 6.29. This value is within the healthy range. It has decreased from 6.43 (Mar 24) to 6.29, marking a decrease of 0.14.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 3.75. This value is within the healthy range. It has decreased from 3.80 (Mar 24) to 3.75, marking a decrease of 0.05.
- For Enterprise Value (Cr.), as of Mar 25, the value is 1,976.83. It has decreased from 2,921.68 (Mar 24) to 1,976.83, marking a decrease of 944.85.
- For EV / Net Operating Revenue (X), as of Mar 25, the value is 2.42. This value is within the healthy range. It has decreased from 4.27 (Mar 24) to 2.42, marking a decrease of 1.85.
- For EV / EBITDA (X), as of Mar 25, the value is 13.43. This value is within the healthy range. It has decreased from 21.79 (Mar 24) to 13.43, marking a decrease of 8.36.
- For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 2.18. This value is within the healthy range. It has decreased from 3.85 (Mar 24) to 2.18, marking a decrease of 1.67.
- For Retention Ratios (%), as of Mar 25, the value is 91.08. This value exceeds the healthy maximum of 70. It has increased from 90.73 (Mar 24) to 91.08, marking an increase of 0.35.
- For Price / BV (X), as of Mar 25, the value is 3.37. This value exceeds the healthy maximum of 3. It has decreased from 7.43 (Mar 24) to 3.37, marking a decrease of 4.06.
- For Price / Net Operating Revenue (X), as of Mar 25, the value is 2.18. This value is within the healthy range. It has decreased from 3.85 (Mar 24) to 2.18, marking a decrease of 1.67.
- For EarningsYield, as of Mar 25, the value is 0.03. This value is below the healthy minimum of 5. It has increased from 0.02 (Mar 24) to 0.03, marking an increase of 0.01.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
| Strength | Weakness |
|---|---|
|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Carysil Ltd:
- Net Profit Margin: 7.88%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 17.5% (Industry Average ROCE: 12.44%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: 12.1% (Industry Average ROE: 14.63%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 3.75
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 0.87
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 30.9 (Industry average Stock P/E: 40.83)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 0.5
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: 7.88%
About the Company - Qualitative Analysis
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| Ceramics/Tiles/Sanitaryware | A-702, 7th Floor, Kanakia Wall Street, Mumbai Maharashtra 400093 | Contact not found |
| Management | |
|---|---|
| Name | Position Held |
| Mr. Chirag Parekh | Chairman & Managing Director |
| Mr. Anand Sharma | Executive Director & Group CFO |
| Dr. Sonal V Ambani | Independent Director |
| Mr. Rustam N Mulla | Independent Director |
| Mrs. Katja Larsen | Independent Director |
| Mr. Prabhakar R Dalal | Independent Director |
| Mr. Pradyumna R Vyas | Independent Director |
| Dr. Savan Godiawala | Independent Director |
FAQ
What is the intrinsic value of Carysil Ltd?
Carysil Ltd's intrinsic value (as of 07 January 2026) is ₹715.22 which is 18.63% lower the current market price of ₹879.00, indicating overvalued. Calculated using the PE ratio method, this valuation considers the company's ₹2,503 Cr. market cap, FY2025-2026 high/low of ₹1,072/482, reserves of ₹560 Cr, and liabilities of ₹1,046 Cr.
What is the Market Cap of Carysil Ltd?
The Market Cap of Carysil Ltd is 2,503 Cr..
What is the current Stock Price of Carysil Ltd as on 07 January 2026?
The current stock price of Carysil Ltd as on 07 January 2026 is ₹879.
What is the High / Low of Carysil Ltd stocks in FY 2025-2026?
In FY 2025-2026, the High / Low of Carysil Ltd stocks is ₹1,072/482.
What is the Stock P/E of Carysil Ltd?
The Stock P/E of Carysil Ltd is 30.9.
What is the Book Value of Carysil Ltd?
The Book Value of Carysil Ltd is 199.
What is the Dividend Yield of Carysil Ltd?
The Dividend Yield of Carysil Ltd is 0.27 %.
What is the ROCE of Carysil Ltd?
The ROCE of Carysil Ltd is 15.4 %.
What is the ROE of Carysil Ltd?
The ROE of Carysil Ltd is 14.5 %.
What is the Face Value of Carysil Ltd?
The Face Value of Carysil Ltd is 2.00.